Lanolimus (Everolimus) Tablet

Description

Description

This page contains brief details about the drug everolimus, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Everolimus is an immunosuppressant that was approved for its medical use on 30th March 2009.

Mechanism of Action of Everolimus

It contains the active ingredient everolimus, which inhibits the activity of a protein called mammalian target of rapamycin (mTOR), which regulates cell growth. This drug can slow the growth of abnormal cancer cells by blocking the mTOR protein. Everolimus helps to reduce the size of tumours and improve outcomes in patients.

Uses of Everolimus

Everolimus has been developed to treat advanced hormone receptor-positive breast cancer, pancreatic cancer (pancreatic neuroendocrine tumour), and neuroendocrine tumour of the stomach, lung, and intestine that cannot be treated with surgery.

Everolimus Dosage available

Take the Everolimus Tablet as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.